SESSION 3 Fractional Finance Strategies for Every Growth Stage: The Jaguar Health Fractional Finance Playbook

Gliezel David

Director, Technical Accounting Services

SESSION 3 Fractional Finance Strategies for Every Growth Stage: The Jaguar Health Fractional Finance Playbook

Jaguar Health CAO’s Proven Fractional Playbook for Public Company Growth​

For a publicly-traded life sciences company, the stakes for financial reporting are as high as they get. There is zero room for error, yet resources are fiercely guarded. How does a company navigate SEC compliance, SOX controls, and rapid international growth while remaining agile?


In a standout session from our “The Future is Fractional” virtual conference, Scrubbed’s Gliezel David sat down with Ismaila “Ish” Sougoufara, Chief Accounting Officer and SVP of Finance at Jaguar Health, to discuss this exact challenge.


Ish provided a candid, practical playbook for how Jaguar Health, a commercial-stage pharma company, moved from having compliance issues to a model of excellence by strategically integrating a fractional partnership.


Here are the key takeaways from their conversation.


Navigating Compliance with a High-Risk Public Company

For a biotech company, the core challenge is a paradox. Ish explained that financing is hard to secure, forcing efficiency, but as a public entity, you must also meet strict compliance demands.


He warned leaders about the dangers of a “DIY” approach to accounting to save costs, calling it “high risk, and very low reward.”


“It is not a field where you can learn it on the fly,” Ish stated. “Trying to do it on your own… to save costs, it will surely come back against you… What you don’t want to see is the qualified opinion.”


Building a Partnership on "Commitment and Sacrifice"

Ish was clear that the type of partnership is what determines success or failure. For him, the key was finding a fractional team that did more than just clock in.


"Talent is never enough," he shared.
"You have to have the care, commitment, and sacrifice."


The Scrubbed team’s proactive mindset and service delivery is ultimately what made this model work, cementing their role as an extension of the core team rather than a vendor. They weren’t just treated like employees, but acted like them. Ish highlighted this, noting that the team was “working as part of Jaguar employees, never as outside consultants,” and would even proactively provide “advice, when… not even asked” by “thinking ahead [and] understanding the global future.”


Earning Board and Auditor Buy-In

How do you get your board and auditors comfortable with a fractional expert handling critical SEC reporting? For Ish, the answer was in the results.


“Quality speaks for itself,” he said. “Before Scrubbed, Jaguar had serious compliance issues. It’s public. The turnaround in the quality of the financial reporting… the removal of the material weakness is public… That has been accomplished [with] Scrubbed’s commitment, quality, and competence.”


This outcome made the partnership an “easy sell.” Ish noted

Scrubbed is not seen as fractional. We refer to Scrubbed as our company in the Philippines. It’s an integral part of Jaguar.”
- Ismaila Sougoufara, Chief Accounting Officer & Senior VP Finance


Scaling the Partnership from Compliance to FP&A

The partnership didn’t just solve a problem; it scaled with the company. Ish explained that the relationship evolved as Jaguar Health grew, expanding from foundational 10Q and 10K reporting to complex areas like technical consultations and memo preparations, to reconciliations, to valuations, to tax as they expanded internationally into Italy.


This scalability, combined with a robust business continuity plan from the fractional partner, ensured that even with team changes, the quality of service was never impacted

Watch the Full Session

To hear all of Ish’s insights, including his final advice on why fractional support is “a must” for small-cap companies and the importance of choosing the right company, you can watch the full session recording.

GET YOUR ON-DEMAND ACCESS
Watch the Full Session

Related Content

Blogs

5 Financial Pillars That Can Help CFOs Drive Success

5 Financial Pillars That Can Help CFOs Drive Success

The accounting and finance functions and the role of the CFO are both changing dramatically, with the CFO now expected to help lead a company’s transformation alongside other C-suite executives. By leveraging these 5 financial pillars, CFOs can play an integral role strategically in driving their businesses to thrive and succeed. Pillar #1: A Sound Finance Strategy Most new businesses are born from an idea for an innovative product or service, so their initial strategic planning efforts tend to focus on developing a product or service strategy. As the company’s core offering takes shape, the strategy discussion shifts to the many functions needed to get the product into the market and to keep clients satisfied, like sales, marketing, and customer service. It’s rare for companies to develop a finance strategy at the onset. But that’s a big miss, because it takes significant financial resources to scale a business effectively. Without a well-developed finance strategy, the company runs the risk of being in reactive mode financially—always scrambling for the funds to invest in staff, equipment, or technology, or to expand into new geographic and vertical markets. It’s critical for the CFO to develop and execute on a sound finance strategy, perhaps now more than ever. While the exercise will likely involve cross-functional participation, it’s up to the CFO to take the lead, ensuring that strategy and funding are in place or readily available to fuel the company’s growth. Pillar #2: The Right Resources Even the best products are destined to fail unless they’re supported by the right resources, including people, processes, and technology. At every stage in a company’s life cycle, decisions about how and when to invest in those resources can make a major impact on the trajectory of the business. For example, the right technology platform is critical to gathering and disseminating the financial information that production, marketing, human resource (HR), and other functions need to make the most informed operational decisions. But while some early-stage companies are quick to invest in highly sophisticated financial technology, they don’t always maximize their use of the functionality, which greatly reduces return on investments (ROI). Or when it comes to building the right talent, they might staff up internally on functions that could be handled more cost-effectively in an outsourced mode, especially in the early stages or at times of rapid expansion. By identifying and investing in the optimal resources, aligned to the company’s needs based on its life cycle phase, the CFO can help position the business for profitable growth.   Pillar #3: A Cross-Functional Approach  For decades, accounting and finance typically operated in a vacuum. Today, the CFO’s reach spans far beyond accounting and financial reporting, directly touching many operational decisions that are integral to the company’s ability to thrive. The most successful CFOs find ways to work effectively across departments and functional groups. When the CTO wants to invest in a new enterprise resource planning system or the head of HR wants to increase salaries to better compete for talent, the CFO is actively engaged—lending unique skills and capabilities to the decision-making process, conducting the necessary analyses, and ensuring the decision is on target strategically and viable financially. By building strong relationships across the organization and establishing processes to ensure finance is integral to operational decision-making, the CFO can play a central role in driving the business’s success.   Pillar #4: A Willingness to Embrace Analytics In nearly every function in every organization, the tool that helps operational leaders measure performance today is analytics. While it could be easy to dismiss analytics as a buzzword, the right analytics provide businesses with information that is much more actionable and insightful than the static reports of the past. CFOs that take a lead role in driving their organizations’ success readily adopt analytics and help each functional group determine the most appropriate key performance measures (KPIs) for their needs. For instance, the CFO might collaborate with those responsible for risk management to develop KPIs for revenue and cash flow and use analytics to keep tabs on how those figures are trending. Sometimes those analytics translate directly to dollars; other times, they provide the data needed to guide more qualitative decisions.   By embracing analytics, the CFO can manage the day-to-day financial operations more effectively and help leaders across the enterprise use the most relevant metrics to guide operational decision-making and management.      Pillar #5: An Innovative Workforce Strategy Dramatic changes in how and where we work, fueled recently by the Covid19 pandemic, have forever altered the way businesses approach staffing. Those that adopt an innovative workforce strategy place themselves in the strongest position to succeed, even despite a tight labor market. CFOs that take a modern view of staffing recognize that the current business environment opens the door to more flexible work arrangements that go far beyond providing convenience for employees; they can also prove more cost-effective for the company. Outsourcing certain business functions is a prime example. CFOs should have input into decisions about which functions might be outsourced effectively, as well as the processes and technologies needed to support this arrangement for a successful experience. By championing an innovative workforce strategy, the CFO can help the organization overcome staffing constraints, mitigate the risk of turnover, gain crucial capabilities that aren’t resident in-house, and flex in sync with customer demands and expectations.

Read More >
Blogs

How Biotech Firms Prepare Financials for IPO

How Biotech Firms Prepare Financials for IPO

Biotech IPOs experienced a surge in 2021 , with more than 100 deals raising billions in fresh capital. However, enthusiasm cooled quickly. By 2022, deal volume dropped dramatically, and in 2024, only 24 US biopharma IPOs were completed , the lowest number in more than a decade. Despite this decline, the year ended with signs of recovery. According to GlobalData , the global biotech IPOs in 2024 raised $8.52 billion across 50 deals, the strongest performance since 2021. Investors, however, are becoming cautious and highly selective, favoring firms with later-stage pipelines and strong financial discipline. In this climate, financial preparation is the difference between stumbling through an IPO and stepping into the public markets with confidence. Partnering with specialized experts ensures that your firm is ready when opportunity arrives. To facilitate a successful IPO, here are the key steps biotech firms should take to prepare their financials: 1. Start with a Strategic IPO Roadmap Most biotech firms begin preparing for an IPO 12 to 24 months prior to filing. This lead time is crucial, especially since meeting SEC reporting requirements, obtaining audited financial statements, and implementing system upgrades cannot be done overnight. A Reuters survey of healthcare executives in late 2024 reflected this cautious reality: while 64% expected more IPOs in 2025, many anticipated only modest growth compared to the historic highs of 2020 – 2021. With market timing still uncertain and investors highly selective, firms that create a structured plan, covering accounting, governance, and reporting milestones, will be in the best position to move quickly when the right window opens. 2. Build Scalable, Compliant Financial Reporting Systems and Processes One of the biggest challenges for biotech firms preparing for an IPO is upgrading their financial reporting systems and processes to meet public company standards. Many operate with lean finance teams and systems designed for private reporting. However, going public necessitates a significant step up in rigor, speed, and transparency. Some key elements to focus on include: Internal controls that meet Sarbanes-Oxley requirements , particularly SOX 404, which mandates an annual assessment of the effectiveness of internal controls over financial reporting. GAAP-compliant accounting policies and processes that address critical and complex areas, such as Revenue Recognition (ASC 606) for collaboration and licensing agreements, R&D Costs (ASC 730 ), which must be expensed as incurred, the classification of Financial Instruments as debt or equity, and the accounting for Intangible Assets. Scalable systems that can manage quarterly SEC reporting and investor communications effectively. Investing in these systems early can help reduce the risk of costly errors and position finance teams to meet tight deadlines once the firm goes public. 3. Prepare and Audit Historical Financial Statements The SEC typically requires biotech firms to present at least two years of audited financial statements (sometimes three), along with interim quarterly data. These reports must meet PCAOB standards , which are more stringent than audits for private firms. A key distinction is the requirement for auditors to review and report on the effectiveness of internal controls over financial reporting (ICFR). This phase can be particularly complex for biotech firms, whose expenses are often R&D-driven and may include licensing deals, milestone payments, and joint venture arrangements. As EisnerAmper notes, the IPO process is “stressful and lengthy,” and should never be left to the last minute. For biotech firms with limited finance teams, the challenge is even greater. Fortunately, there are several things you can do to reduce delays once the IPO process is underway, such as engaging auditors early, closing historical books cleanly, and addressing technical accounting questions ahead of time. 4. Manage Cap Tables, Valuation, and Forecasts Biotech firms often have complicated capitalization tables, especially after multiple funding rounds involving preferred stock, convertible notes, or warrants. This complexity can create challenges in analyzing financial instruments for features such as beneficial conversion features or embedded derivatives, which may affect their classification as debt or equity. Valuation also presents unique challenges. Unlike commercial-stage companies, pre-revenue biotech firms often rely on the potential of their drug pipelines and future market opportunities for their valuations. In today’s environment, investors have become significantly more discerning. As Wellington Managemen t observed in 2025, biotech IPO investors are focusing on valuation discipline, differentiation, and clinical maturity when assessing new offerings. This indicates that while early-stage science may excite venture investors, the public markets expect more clinical and financial proof points before committing capital. 5. Form the Right IPO Team An IPO requires a cross-functional team of auditors, attorneys, investment bankers, and investor relations professionals. Within the firm, the finance team plays a crucial role by collaborating with external advisors to draft the S-1, prepare roadshow materials, and respond to due diligence inquiries. For biotech firms, having a reliable outsourced team adds a layer of financial discipline, providing accounting support, IPO readiness consulting, and CPA-level expertise. This ensures financial accuracy and consistency while freeing up leadership to focus on science, strategy, and investor engagement. 6. Practice Due Diligence and Run IPO Simulations Investor and regulatory due diligence for biotech IPOs can be particularly intensive. In addition to financial reviews, biotech firms face scrutiny over intellectual property, clinical trial data, and regulatory filings . By conducting mock diligence sessions and IPO “practice periods”, you can identify weaknesses before they become obstacles. The Financial Times recently highlighted how Boston’s biotech hub, once booming, has been rattled by funding slowdowns and policy uncertainty This has made investors more selective about which firms to back, which shows that practicing IPO routines, from documentation to financial mock runs, is more important than ever. 7. Craft a Compelling IPO Narrative and Communications Plan That said, numbers alone won’t carry a biotech IPO. Investors seek a clear financial narrative that connects the science to the strategy. A compelling story highlights how capital raised will be utilized, how long current funding will last, and what milestones investors can expect. And strong financial storytelling requires accurate, timely, and transparent reporting . This is another area where outsourcing can help biotech firms, ensuring the numbers support the narrative and instill confidence in prospective investors. 8. Plan for Post-IPO Sustainability The IPO is just the beginning. Once public, biotech firms must maintain the following: Quarterly and annual SEC reporting Sarbanes-Oxley compliance Investor relations and financial communications Leadership must also balance financial transparency with the unpredictable timelines of drug development. The firms that plan for sustainability beyond the IPO, by establishing robust systems and securing the right partners, will be best positioned for long-term success. Conclusion The biotech IPO market is inherently cyclical, and the last few years have proven just how quickly conditions can change. In a market where investors are cautious and selective, it’s the firms that develop strong financial systems, effectively manage complex cap tables, and communicate a compelling narrative that stands out. By partnering with trusted experts like Scrubbed, biotech firms can successfully navigate the intricacies of IPO preparation and enter the public markets with confidence. We serve as an extension of your finance team, from preparing audited-ready financial statements and enhancing financial systems to supporting IPO readiness and ongoing compliance. If your biotech firm is considering an IPO or wants to explore what it would take to get IPO-ready, now is the time to start planning. Schedule a free consultation today and learn how our team of CPAs and financial experts can help you enter the public markets with confidence.

Read More >
Blogs

Untangling Three Years of E-Commerce Data (And the Lesson for Scaling Teams)

Untangling Three Years of E-Commerce Data (And the Lesson for Scaling Teams)

High-growth e-commerce companies often scale their transaction volume much faster than their accounting infrastructure. When the books haven’t been reconciled in months, or even years, teams often resort to pulling cash balances straight from the bank, bypassing the accounting system entirely. Fixing this isn’t just about cleaning up a backlog. It requires a forensic approach to historical data and structural system integrations to restore leadership’s trust in their financial dashboard. You can’t steer a ship if you don’t trust the gauges. I was reminded of this early in my time at Scrubbed when I sat down to review the weekly cash position report for a fast-growing e-commerce client. On the surface, the business was moving at an incredible pace. But beneath the surface, the execution layer was fracturing. When I looked closely at how the client was reporting their cash, I noticed something concerning: they were pulling their balances directly from the bank statements, completely bypassing their own accounting system. The reason, I discovered, is that the system couldn’t be trusted. The current amount of cash in the bank did not reconcile with the books, and it hadn’t for a very long time. Because of the sheer volume of e-commerce transactions and the delay in clearing times across various payment portals, the team had lost visibility into which funds were deposited in transit and which were simply missing. When I looked into the backlog, I discovered the disconnect stretched back three years. It was thousands of unreconciled transactions. This isn’t an uncommon story. When a business experiences rapid growth, especially in e-commerce, where money floats across multiple gateways before hitting the bank, the volume of transactions often increases faster than the internal structure can handle. The team was doing exactly what they were hired to do, and the work hadn’t changed; the volume had. And eventually, the capacity simply failed. Stopping the Bleeding When I realized the scope of the problem, our official engagement with the client was strictly limited. But as a former auditor, I couldn’t just look the other way. If your bank balance is far off from your book balance, every management report you produce is built on unstable ground. You can’t accurately forecast, you can’t confidently deploy capital, and if you try to reconcile the gap, you can’t simply guess which accounts need adjusting. You have to know the why behind every dollar. Before we could fix the past, we had to protect the present. I sat down with the client’s newly hired Controller, who also happened to be a former auditor, and we aligned on a dual strategy. Step one: Stop the bleeding. We immediately implemented a strict, weekly reconciliation process for all current transactions. Moving forward, the books would be accurate. Step two: The forensic cleanup. We had to dig through three years of history to catch up. The Architecture of Trust Unfortunately, there was no shortcut. At the time, the API integration between the client’s payment portals and NetSuite wasn’t functioning correctly. It couldn’t automatically match a $10,000 bulk bank deposit to the hundreds of $50 and $100 individual sales that comprised it. So, we did the heavy lifting. I started manually ticking and tying transactions one by one, verifying if they were valid in the payment platform and if they had cleared the bank. Because the volume was so massive, I eventually brought in a dedicated team of Scrubbed professionals. Since the majority of our team comes from an audit background, they thrive in this kind of investigative work. We moved through the data methodically, identifying sales refunds, credit memos, and double-bookings that had quietly skewed the client’s financial reality for years. For the few historical anomalies where the cost of investigation outweighed the financial benefit, we worked transparently with the client to park them in an agreed-upon expense account, ensuring the balance sheet remained clean and audit-ready. From Cleanup to Continuity The actual cleanup was intensive, but it didn’t take us long to execute because we had the flexible capacity to scale our team exactly when the client needed it. But the real victory wasn’t in us fixing the historical data, but in fixing the entire system. Once the investigation was complete, we worked with the client to successfully implement the system integrations. Today, when those bulk deposits hit the bank, the matching process is automated and visible. The founders and the CFO no longer have to bypass their own system to know how much cash they have. They can simply export the report directly from their accounting software and trust that the numbers are real. The closes are predictable, rework has vanished, and leadership spends less time questioning the data and more time making decisions. The Takeaway Nowadays, it can be tempting for accounting teams to simply stay in their lane and execute only what is explicitly asked of them. But a true financial partnership requires going beyond the scope of work to care for the fundamental health of the client’s business. When you uncover a massive discrepancy, it can initially cause friction. Clients will naturally ask, “How did this happen?” But when you approach the problem not just as a task to complete, but as an operational threat you are taking ownership of, the dynamic shifts. You aren’t just fixing spreadsheets; you are protecting their business. Whenever I feel overwhelmed by the sheer volume of a complex financial cleanup, I always go back to my why. The purpose of this work isn’t just compliance. The purpose is clarity. And clarity is the strongest form of confidence you can give a growing business. Key Takeaways Volume breaks legacy structure: E-commerce scaling often causes transaction volume to overwhelm manual reconciliation processes. It is an execution issue, not a performance issue. Bypassing the system is a red flag: Pulling cash balances directly from the bank because the accounting system is unreliable obscures your true financial reality. Triage must precede cleanup: Restoring trust requires a dual approach: stopping the bleeding by strictly reconciling current transactions, then forensically investigating the backlog. Integrations require a clean foundation: Automated APIs are essential for e-commerce efficiency, but they cannot fix bad historical data. They must be implemented after the cleanup. Partnership means ownership: True financial partners don’t just execute the immediate scope; they take ownership of operational threats to protect the clarity of the business.

Read More >

Contact Information

SF Bay Area Headquarters
111 Anza Boulevard, Suite 320, Burlingame, CA 94010, United States

Phone: (800)837-5160
Email: [email protected]

"Scrubbed" is the brand name under which Scrubbed Advisory, LLC and Scrubbed Assurance, LLP provide professional services. Scrubbed Advisory, LLC and Scrubbed Assurance, LLP practice in an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations, and professional standards. Scrubbed Assurance, LLP is a licensed independent CPA firm that provides attest services to its clients, and Scrubbed Advisory, LLC provides tax, finance, and support services to its clients. Scrubbed Advisory, LLC is not a licensed CPA firm.

Copyright © Scrubbed. All rights reserved.